Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

FIRST FAILED MACULAR HOLE SURGERY OR REOPENING OF A PREVIOUSLY CLOSED HOLE: Do We Gain by Reoperating?-A Systematic Review and Meta-analysis.

Reid GA, McDonagh N, Wright DM, Yek JTO, Essex RW, Lois N.

Retina. 2019 Jul 22. doi: 10.1097/IAE.0000000000002564. [Epub ahead of print]

PMID:
31335482
2.

STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes.

Chen M, Obasanmi G, Armstrong D, Lavery NJ, Kissenpfennig A, Lois N, Xu H.

J Neuroinflammation. 2019 Jul 8;16(1):138. doi: 10.1186/s12974-019-1533-1.

3.

Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD).

Lois N, Cook J, Aldington S, Waugh N, Mistry H, Sones W, McAuley D, Aslam T, Bailey C, Chong V, Ghanchi F, Scanlon P, Sivaprasad S, Steel D, Styles C, McNally C, Rice R, Prior L, Azuara-Blanco A; EMERALD Study Group.

BMJ Open. 2019 Jun 28;9(6):e027795. doi: 10.1136/bmjopen-2018-027795.

4.

IMPACT OF RETINAL ISCHEMIA ON FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN PATIENTS WITH RETINAL VEIN OCCLUSION.

Khayat M, Wright DM, Yeong J, Xu D, Donley C, Lakshmipathy GR, Low MK, White N, Williams M, Lois N.

Retina. 2019 May 30. doi: 10.1097/IAE.0000000000002571. [Epub ahead of print]

PMID:
31157714
5.

Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Morata L, Cobo J, Fernández-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, González Ruano P, Rico Nieto A, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cuadra F, Del Arco A, Del Toro MD, Guio L, Jimenez-Beatty D, Lois N, Martin O, Martínez Alvarez RM, Martinez-Marcos FJ, Porras L, Ramírez M, Vergas García J, Soriano A.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02280-18. doi: 10.1128/AAC.02280-18. Print 2019 May.

6.

PRAGMATISM OF RANDOMIZED CLINICAL TRIALS ON RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA: Impact on Clinical Outcomes.

Stewart S, Yeong JL, Virgili G, Azuara-Blanco A, Lois N.

Retina. 2019 Feb 14. doi: 10.1097/IAE.0000000000002476. [Epub ahead of print]

PMID:
30789463
7.

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial.

Lois N, Gardner E, Waugh N, Azuara-Blanco A, Mistry H, McAuley D, Acharya N, Aslam TM, Bailey C, Chong V, Downey L, Eleftheriadis H, Fatum S, George S, Ghanchi F, Groppe M, Hamilton R, Menon G, Saad A, Sivaprasad S, Shiew M, Steel DH, Talks JS, Adams C, Campbell C, Mills M, Clarke M; DIAMONDS Study Group.

Trials. 2019 Feb 12;20(1):122. doi: 10.1186/s13063-019-3199-5.

8.

Reply to Correspondence by Calugaru and Calugaru to the Article Entitled "Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion" by Khayat et al.

Khayat M, Williams M, Lois N.

Surv Ophthalmol. 2019 Jul - Aug;64(4):593-594. doi: 10.1016/j.survophthal.2019.01.004. Epub 2019 Jan 23. No abstract available.

PMID:
30682402
9.

Contrasting phylogeographic pattern among Eudyptes penguins around the Southern Ocean.

Frugone MJ, Lowther A, Noll D, Ramos B, Pistorius P, Dantas GPM, Petry MV, Bonadonna F, Steinfurth A, Polanowski A, Raya Rey A, Lois NA, Pütz K, Trathan P, Wienecke B, Poulin E, Vianna JA.

Sci Rep. 2018 Nov 30;8(1):17481. doi: 10.1038/s41598-018-35975-3.

10.

Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 Signaling.

Vilà-González M, Kelaini S, Magee C, Caines R, Campbell D, Eleftheriadou M, Cochrane A, Drehmer D, Tsifaki M, O'Neill K, Pedrini E, Yang C, Medina R, McDonald D, Simpson D, Zampetaki A, Zeng L, Grieve D, Lois N, Stitt AW, Margariti A.

Stem Cells. 2019 Feb;37(2):226-239. doi: 10.1002/stem.2936. Epub 2018 Nov 17.

11.

Polarized retinal pigment epithelium generates electrical signals that diminish with age and regulate retinal pathology.

Cao L, Liu J, Pu J, Milne G, Chen M, Xu H, Shipley A, Forrester JV, McCaig CD, Lois N.

J Cell Mol Med. 2018 Nov;22(11):5552-5564. doi: 10.1111/jcmm.13829. Epub 2018 Aug 30.

12.

Fenofibrate for Diabetic Retinopathy.

Stewart S, Lois N.

Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):422-426. doi: 10.22608/APO.2018288. Epub 2018 Jul 30. Review.

PMID:
30058790
13.

Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.

Waugh N, Loveman E, Colquitt J, Royle P, Yeong JL, Hoad G, Lois N.

Health Technol Assess. 2018 May;22(27):1-168. doi: 10.3310/hta22270.

14.

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.

Mikhail M, Stewart S, Seow F, Hogg R, Lois N.

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1411-1418. doi: 10.1007/s00417-018-4009-6. Epub 2018 May 19.

15.

Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.

Khayat M, Williams M, Lois N.

Surv Ophthalmol. 2018 Nov - Dec;63(6):816-850. doi: 10.1016/j.survophthal.2018.04.005. Epub 2018 Apr 27. Review.

PMID:
29705175
16.

Different lasers and techniques for proliferative diabetic retinopathy.

Moutray T, Evans JR, Lois N, Armstrong DJ, Peto T, Azuara-Blanco A.

Cochrane Database Syst Rev. 2018 Mar 15;3:CD012314. doi: 10.1002/14651858.CD012314.pub2. Review.

17.

Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?

Mistry H, Auguste P, Lois N, Waugh N.

BMJ Open Ophthalmol. 2017 Sep 25;2(1):e000021. doi: 10.1136/bmjophth-2016-000021. eCollection 2017.

18.

Animal Models of Retinal Vein Occlusion.

Khayat M, Lois N, Williams M, Stitt AW.

Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6175-6192. doi: 10.1167/iovs.17-22788. Review.

PMID:
29222552
19.

Instrumental variable methods for a binary outcome were used to informatively address noncompliance in a randomized trial in surgery.

Cook JA, MacLennan GS, Palmer T, Lois N, Emsley R.

J Clin Epidemiol. 2018 Apr;96:126-132. doi: 10.1016/j.jclinepi.2017.11.011. Epub 2017 Nov 20.

20.

Erythropoietin in diabetic retinopathy.

Reid G, Lois N.

Vision Res. 2017 Oct;139:237-242. doi: 10.1016/j.visres.2017.05.010. Epub 2017 Aug 8. Review.

21.

The Epidemiology of Stargardt Disease in the United Kingdom.

Spiteri Cornish K, Ho J, Downes S, Scott NW, Bainbridge J, Lois N.

Ophthalmol Retina. 2017 Nov - Dec;1(6):508-513. doi: 10.1016/j.oret.2017.03.001. Epub 2017 Apr 21.

PMID:
31047443
22.

The progress in understanding and treatment of diabetic retinopathy.

Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, Gardiner TA, Lyons TJ, Hammes HP, Simó R, Lois N.

Prog Retin Eye Res. 2016 Mar;51:156-86. doi: 10.1016/j.preteyeres.2015.08.001. Epub 2015 Aug 18. Review.

PMID:
26297071
23.

Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.

Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N.

Health Technol Assess. 2015 Jul;19(51):v-xxviii, 1-247. doi: 10.3310/hta19510. Review.

24.

Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review.

Castillo MM, Mowatt G, Elders A, Lois N, Fraser C, Hernández R, Amoaku W, Burr JM, Lotery A, Ramsay CR, Azuara-Blanco A.

Ophthalmology. 2015 Feb;122(2):399-406. doi: 10.1016/j.ophtha.2014.07.055. Epub 2014 Oct 22. Review.

PMID:
25444343
25.

Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation.

Mowatt G, Hernández R, Castillo M, Lois N, Elders A, Fraser C, Aremu O, Amoaku W, Burr J, Lotery A, Ramsay C, Azuara-Blanco A.

Health Technol Assess. 2014 Dec;18(69):1-254. doi: 10.3310/hta18690. Review.

26.

Non-Proliferative Diabetic Retinopathy: is It Cost-Effective to Treat Early?

Mistry H, Auguste P, Lois N, Waugh N.

Value Health. 2014 Nov;17(7):A609. doi: 10.1016/j.jval.2014.08.2130. Epub 2014 Oct 26. No abstract available.

27.

Optical coherence tomography for the diagnosis of neovascular age-related macular degeneration: a systematic review.

Castillo MM, Mowatt G, Lois N, Elders A, Fraser C, Amoaku W, Burr JM, Lotery AJ, Ramsay CR, Azuara-Blanco A.

Eye (Lond). 2014 Dec;28(12):1399-406. doi: 10.1038/eye.2014.214. Epub 2014 Sep 19. Review.

28.

Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis.

Ford JA, Shyangdan D, Uthman OA, Lois N, Waugh N.

BMJ Open. 2014 Jul 23;4(7):e005292. doi: 10.1136/bmjopen-2014-005292.

29.

Endothelial progenitor cells in diabetic retinopathy.

Lois N, McCarter RV, O'Neill C, Medina RJ, Stitt AW.

Front Endocrinol (Lausanne). 2014 Apr 9;5:44. doi: 10.3389/fendo.2014.00044. eCollection 2014. Review.

30.

Treatments for macular oedema following central retinal vein occlusion: systematic review.

Ford JA, Clar C, Lois N, Barton S, Thomas S, Court R, Shyangdan D, Waugh N.

BMJ Open. 2014 Feb 10;4(2):e004120. doi: 10.1136/bmjopen-2013-004120. Review.

31.

Fundus autofluorescence in patients with retinal pigment epithelial (RPE) tears: an in-vivo evaluation of RPE resurfacing.

Mendis R, Lois N.

Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1059-63. doi: 10.1007/s00417-013-2549-3. Epub 2014 Jan 10.

PMID:
24407824
32.

Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole.

Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C, Tadayoni R, la Cour M, Christensen U, Kwok AK.

Ophthalmology. 2014 Mar;121(3):649-55. doi: 10.1016/j.ophtha.2013.10.020. Epub 2013 Dec 4. Review.

PMID:
24314837
33.

A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

Fujinami K, Lois N, Mukherjee R, McBain VA, Tsunoda K, Tsubota K, Stone EM, Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M.

Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90. doi: 10.1167/iovs.13-12104.

PMID:
24265018
34.

Giant retinal tears.

Shunmugam M, Ang GS, Lois N.

Surv Ophthalmol. 2014 Mar-Apr;59(2):192-216. doi: 10.1016/j.survophthal.2013.03.006. Epub 2013 Oct 15. Review.

PMID:
24138895
35.

Reply: To PMID 22846802.

Lois N, McBain V, Abdelkader E, Scott NW, Kumari R.

Retina. 2013 Oct;33(9):1998-9. doi: 10.1097/IAE.0b013e31829f3f0a. No abstract available.

PMID:
23903790
36.

Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).

Spiteri Cornish K, Lois N, Scott N, Burr J, Cook J, Boachie C, Tadayoni R, la Cour M, Christensen U, Kwok A.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD009306. doi: 10.1002/14651858.CD009306.pub2. Review.

PMID:
23740611
37.

A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations.

Fujinami K, Lois N, Davidson AE, Mackay DS, Hogg CR, Stone EM, Tsunoda K, Tsubota K, Bunce C, Robson AG, Moore AT, Webster AR, Holder GE, Michaelides M.

Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13. doi: 10.1016/j.ajo.2013.01.018. Epub 2013 Mar 15.

PMID:
23499370
38.

Advances in our understanding of diabetic retinopathy.

Stitt AW, Lois N, Medina RJ, Adamson P, Curtis TM.

Clin Sci (Lond). 2013 Mar 13;125(1):1-17. doi: 10.1042/CS20120588. Review.

PMID:
23485060
39.

Current treatments in diabetic macular oedema: systematic review and meta-analysis.

Ford JA, Lois N, Royle P, Clar C, Shyangdan D, Waugh N.

BMJ Open. 2013 Mar 1;3(3). pii: e002269. doi: 10.1136/bmjopen-2012-002269.

40.

Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy.

Lois N, McBain V, Abdelkader E, Scott NW, Kumari R.

Retina. 2013 Jan;33(1):13-22. doi: 10.1097/IAE.0b013e3182657fff.

PMID:
22846802
41.

Progression of retinal pigment epithelial atrophy in stargardt disease.

McBain VA, Townend J, Lois N.

Am J Ophthalmol. 2012 Jul;154(1):146-54. doi: 10.1016/j.ajo.2012.01.019. Epub 2012 Mar 30.

PMID:
22464366
42.

Interventions for prevention of giant retinal tear in the fellow eye.

Ang GS, Townend J, Lois N.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006909. doi: 10.1002/14651858.CD006909.pub3. Review.

PMID:
22336825
43.

Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial.

Ternent L, Vale L, Boachie C, Burr JM, Lois N; Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group.

Br J Ophthalmol. 2012 Mar;96(3):438-43. doi: 10.1136/bjophthalmol-2011-300402. Epub 2011 Sep 6.

PMID:
21900224
44.

Heavier-than-water silicone oil mixture as a long-term tamponade agent: a pilot study.

Abdelkader E, Siddiqui RM, Ramalingam S, Murrary A, Lois N.

Ophthalmologica. 2011;226 Suppl 1:60-5. doi: 10.1159/000328215. Epub 2011 Jul 22. Erratum in: Ophthalmologica. 2018;239(1):60.

45.

Geographic atrophy in retinal angiomatous proliferation.

McBain VA, Kumari R, Townend J, Lois N.

Retina. 2011 Jun;31(6):1043-52. doi: 10.1097/IAE.0b013e3181fe54c7.

PMID:
21317834
46.

In vivo safety of trypan blue use in vitreoretinal surgery.

Abdelkader EA, McBain VA, Anand M, Scott NW, Rehman Siddiqui MA, Lois N.

Retina. 2011 Jun;31(6):1122-7. doi: 10.1097/IAE.0b013e3182003adb.

PMID:
21178657
47.

Punctate inner choroidopathy.

Amer R, Lois N.

Surv Ophthalmol. 2011 Jan-Feb;56(1):36-53. doi: 10.1016/j.survophthal.2010.03.009. Epub 2010 Nov 5. Review.

PMID:
21056447
48.

Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.

Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group.

Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1586-92. doi: 10.1167/iovs.10-6287.

PMID:
21051731
49.

Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion.

Xu H, Chen M, Forrester JV, Lois N.

Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):249-55. doi: 10.1167/iovs.10-6001.

PMID:
20720227
50.

Electrical estimulation of retinal pigment epithelial cells.

Gamboa OL, Pu J, Townend J, Forrester JV, Zhao M, McCaig C, Lois N.

Exp Eye Res. 2010 Aug;91(2):195-204. doi: 10.1016/j.exer.2010.04.018. Epub 2010 May 10.

PMID:
20457155

Supplemental Content

Support Center